Trending...
- Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
- Santa Your Way Announces Official 2026 Q4 Holiday Tour: Booking Open For Santa, The 5-star Grinch, And Dual Character Experiences Nationwide
- Las Vegas Attorney Thomas Boley Publishes Free Plain-English Guide to 100 Nevada Criminal Laws, in English and Spanish
With an innovative move to combat semiconductor lead times, component availability issues, and the use of unreliable automotive and COTS parts in space, VORAGO introduces a readily available rad-tolerant Arm® Cortex-M0, VA10805, with TID protection up to 300 krad(Si) for the emerging space market.
AUSTIN, Texas - ncarol.com -- VORAGO Technologies (https://voragotech.com) today announced a product portfolio expansion to include a new radiation-tolerant Arm® Cortex-M0 MCU, VA10805, as a cost-competitive and high reliability solution for LEO, New Space, SmallSat and CubeSat markets.
"As commercialization of space continues to grow, so does the need for reliable, affordable, and immediately available component options for cost-sensitive aerospace projects and missions. VORAGO is proud to be a part of that venture. In recent times, the semiconductor industry has experienced major supply shortages and extensive lead times. Our team at VORAGO recognized this problem and have provided a solution. We are excited to bring to the market our immediately available radiation-tolerant, cost-effective VA10805. – Dr. Hannah Moore, Sr. Manager, Product Management, VORAGO Technologies
More on ncarol.com
Created with VORAGO's patented HARDSIL® technology specifically to provide competitive radiation protection for space applications, the VA10805 provides significantly more total ionizing dose protection than competing products. The VA10805 is an ideal solution for LEO missions, CubeSat and SmallSat constellations in need of immediately available radiation-tolerant microcontroller capabilities.
VORAGO's VA10805 includes the following features and benefits:
"As commercialization of space continues to grow, so does the need for reliable, affordable, and immediately available component options for cost-sensitive aerospace projects and missions. VORAGO is proud to be a part of that venture. In recent times, the semiconductor industry has experienced major supply shortages and extensive lead times. Our team at VORAGO recognized this problem and have provided a solution. We are excited to bring to the market our immediately available radiation-tolerant, cost-effective VA10805. – Dr. Hannah Moore, Sr. Manager, Product Management, VORAGO Technologies
More on ncarol.com
- Jacqui Condon Selected to Workers' Compensation Panels for Three Professional Athlete Associations
- Google Mixed Up KayeDinero and Kayla Dinero. KayeDinero Brought Visual Receipts
- New Metallized PE Film from Pregis Brings Recyclability to High-Barrier Food Packaging at Pack Expo International in Chicago
- Drake Brings Jimmy Brooks Back as KayeDinero Turns Banks Ave Into a Nighttime Visual
- Transformational $104 Million Musculoskeletal Healthcare Opportunity as Expansion Strategy Accelerates for Cardiff Lexington Corp (Stock Symbol: CDIX)
Created with VORAGO's patented HARDSIL® technology specifically to provide competitive radiation protection for space applications, the VA10805 provides significantly more total ionizing dose protection than competing products. The VA10805 is an ideal solution for LEO missions, CubeSat and SmallSat constellations in need of immediately available radiation-tolerant microcontroller capabilities.
VORAGO's VA10805 includes the following features and benefits:
- 50MHz Arm® Cortex® - M0
- Latch-up immunity with HARDSIL® Hardened by Process Technology
- Total Ionizing Dose (TID): 300 krad (Si)
- 23KB Data and 128KB Program Memory
- 1KB One Time Programmable Configuration Memory (OTP)
- Broad range of communication interfaces (I2C, UART, SPI)
- 24 Counter/Timers with Extensive Hardware/Software Triggering
- 56 Multiplexed GPIOs
- Operating temperature range: -55 to 125°C
- Easy-to-design development kit, with exceptional support and service offerings available
- To learn more or request a datasheet, visit VORAGO's Product Page.
Source: VORAGO Technologies
Filed Under: Technology
0 Comments
Latest on ncarol.com
- Inlow Upholstery Encourages Boat Owners to Book Upholstery Projects During the Off-Season
- Port St. Lucie REALTOR® Irene Pernice Earns SFR® Certification
- AMR and UAS Take the Stage at WorldSkills Shanghai 2026
- KayeDinero Named a Song After RetroArch. Gamers Already Know Why
- Drake Says He'll Tour in 2027. KayeDinero Has One Question: Asheville?
- Biophysical Therapeutics brings longevity science to skincare with its new IF1 brand
- JoCa's Echoes of Haworth Sells Out on Opening Night in Mexico City; Artist Heads to San Luis Potosí and Miami Art Week
- Alvear Homes Explains NC vs. SC Property Taxes for Charlotte-Area Homebuyers in 2026
- Home2 Suites by Hilton Lee's Summit, MO Opens to Guests
- Shanghai Chengwei Semiconductor Equipment Launches High Precision Laboratory Central Gas Supply System
- Your Local Pro Expands National Service Network to 273+ Locations Across Plumbing, Cleaning, Landscaping and Hydrovac
- Acuvance Coker Study Finds Experience, Not Supply, Is the Biggest Advanced Practice Provider Workforce Challenge
- Uk Financial Moonshot Token™ Robinhood-chain Goes Live On Tokpie Exchange Tomorrow, With Solana Side Of UKFLMS To Follow In Global Listing Expansion
- KayeDinero Took Her Voice Off the Beat — And Says the Music Got More Personal
- Solid Earth's new "Welcome to Real Estate" campaign introduces RealtyID™: Know Before Your Open the Door
- KayeDinero Didn't Stop Writing. She Stopped Putting Words on the Beat
- Radio Drive's New Album Walk With Me Delivers Two GRAMMY® Submissions Across Rock and Alternative Categories
- Before Python, There Was Chess: KayeDinero Makes Her Next Move With "Checkmate"
- Kaplan Morrell and Attorney Jacqui Condon Selected to Represent Professional Women's Soccer Players in Workers' Compensation Matters
- ClearSight Therapeutics Receives NIH SBIR Phase I Award for Conjunctivitis and EKC Research

